Department of Orthopaedic Surgery, Center for Joint Diseases and Rheumatism, Kyung Hee University Hospital at Gangdong, Seoul, Korea.
Haemophilia. 2014 Jan;20(1):129-32. doi: 10.1111/hae.12244. Epub 2013 Aug 1.
The purpose of this study was to evaluate the efficacy and safety of postoperative wound drain salvage and autotransfusion system in haemophilic patients undergoing elective total knee arthroplasty (TKA). No literature exists on reinfusing drained blood in patient with haemophilia undergoing TKA. Eighty-eight knees of 66 patients received cemented TKA due to end-stage haemophilic arthropathy (group I; with autotransfusion in 59 knees, group II; without autotransfusion in 29 knees). In group I, the postoperative shed blood was transfused within 6 h after surgery. The amount of blood drainage and reinfused blood, rate and amount of allogenic transfusion, postoperative change of haemoglobin level, prothrombin time (PT) and activated partial thromboplastin time were analysed. The mean postoperative blood drainage was 932 ± 479 mL in group I and 830 ± 492 mL in group II (P > 0.05). The mean volume of blood reinfused was 530 ± 265 mL in group I. Allogenic transfusion was needed in six knees (10.2%) of group I and eight knees (27.6%) of group II (P = 0.036). The mean volume of allogenic transfusion was 480 ± 49 mL in group I and 1041 ± 691 mL in group II (P > 0.05). Changes of all the laboratory results before and after TKA showed no statistically significant difference except PT was prolonged in group I (P = 0.008) at postoperative day 1. Moreover, there was no significant complication related to either reinfusion or allogenic transfusion in both groups. This study showed that reinfusion of drained blood is a simple, safe and efficacious method in patients with haemophilia undergoing TKA.
本研究旨在评估术后引流管回收和自体输血系统在择期全膝关节置换术(TKA)的血友病患者中的疗效和安全性。目前尚无关于在接受 TKA 的血友病患者中再输注引流血液的文献。66 例 88 膝因血友病性终末期关节病而行 TKA(组 I:59 膝行自体输血,组 II:29 膝不行自体输血)。组 I 中,术后失血在术后 6 小时内输注。分析了引流量和再输入量、异体输血率和量、术后血红蛋白水平变化、凝血酶原时间(PT)和激活部分凝血活酶时间。组 I 的平均术后引流血量为 932 ± 479 mL,组 II 为 830 ± 492 mL(P > 0.05)。组 I 平均再输入血量为 530 ± 265 mL。组 I 中有 6 膝(10.2%)和组 II 中有 8 膝(27.6%)需要异体输血(P = 0.036)。组 I 异体输血平均量为 480 ± 49 mL,组 II 为 1041 ± 691 mL(P > 0.05)。TKA 前后所有实验室结果的变化均无统计学意义,除组 I 术后第 1 天 PT 延长(P = 0.008)外。此外,两组均未发生与再输注或异体输血相关的明显并发症。本研究表明,在接受 TKA 的血友病患者中,引流血液的再输注是一种简单、安全、有效的方法。